scispace - formally typeset
Search or ask a question
Institution

Health Intervention and Technology Assessment Program

NonprofitNonthaburi, Thailand
About: Health Intervention and Technology Assessment Program is a nonprofit organization based out in Nonthaburi, Thailand. It is known for research contribution in the topics: Health care & Economic evaluation. The organization has 116 authors who have published 206 publications receiving 7185 citations. The organization is also known as: HITAP.


Papers
More filters
Journal ArticleDOI
TL;DR: The burden of mortality and disease attributable to alcohol, both globally and for ten large countries, is quantified and concludes that alcohol consumption is one of the major avoidable risk factors, and actions to reduce burden and costs associated with alcohol should be urgently increased.

3,123 citations

Journal ArticleDOI
TL;DR: The authors in this article reviewed potential challenges to success in each of these dimensions and discussed policy implications. But having licensed vaccines is not enough to achieve global control of COVID-19: they also need to be produced at scale, priced affordably, allocated globally so that they are available where needed, and widely deployed in local communities.

782 citations

Journal ArticleDOI
TL;DR: The iDSI Reference Case is an aid to thought, not a substitute for it, and should not be followed slavishly without regard to context, culture, or history, and can be used as a framework for capacity building and technical assistance in LMICs.

186 citations

Journal ArticleDOI
TL;DR: The development and implementation of a comprehensive national strategic plan related to advanced health biotechnologies, greater investment in R&D and I&E for all stakeholders, collaboration among agencies, harmonisation of reimbursement across public health schemes, and provision of targetedI&E are specifically recommended.
Abstract: Background: Thailand faces a significant burden in terms of treating and managing degenerative and chronic diseases. Moreover, incidences of rare diseases are rising. Many of these—such as diabetes, cancer, and inherited inborn metabolic diseases—have no definite treatments or cure. Meanwhile, advanced health biotechnology has been found, in principle, to be an effective solution for these health problems. Methods: Qualitative approaches were employed to analyse the current situation and examine existing public policies related to advanced health biotechnologies in Thailand. The results of this analysis were then used to formulate policy recommendations. Results: Our research revealed that the system in Thailand in relation to advanced health biotechnologies is fragmented, with multiple unaddressed gaps, underfunding of research and development (R&D), and a lack of incentives for the private sector. In addition, there are no clear definitions of advanced health biotechnologies, and coverage pathways are absent. Meanwhile, false advertising and misinformation are prevalent, with no responsible bodies to actively and effectively provide appropriate information and education (I&E). The establishment of a specialised institution to fill the gaps in this area is warranted. Conclusion: The development and implementation of a comprehensive national strategic plan related to advanced health biotechnologies, greater investment in R&D and I&E for all stakeholders, collaboration among agencies, harmonisation of reimbursement across public health schemes, and provision of targeted I&E are specifically recommended.

170 citations


Network Information
Related Institutions (5)
World Health Organization
22.2K papers, 1.3M citations

86% related

Public Health Research Institute
8.1K papers, 276.9K citations

83% related

National Institute for Health Research
7K papers, 270K citations

82% related

Maastricht University
53.2K papers, 2.2M citations

82% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
20221
202127
202019
201921
201814
201713